Gastrointestinal pathologic findings of teriflunomide associated diarrhea

Mult Scler Relat Disord. 2022 Feb:58:103506. doi: 10.1016/j.msard.2022.103506. Epub 2022 Jan 10.

Abstract

Background: Diarrhea is generally a benign and self-limited adverse effect of teriflunomide. Small intestinal pathology has yet to be described with teriflunomide associated diarrhea.

Objective: To report small intestinal pathology in teriflunomide associated diarrhea.

Methods: Small intestinal and colonic biopsies were obtained from a patient with teriflunomide associated diarrhea.

Results: Small intestinal biopsy demonstrated blunting of villi, increased intraepithelial lymphocytes and expansion of lamina propria. Gliadin and t-transglutaminase antibodies were negative. Diarrhea resolved following elimination of teriflunomide with cholestyramine.

Conclusion: This is the first reported case of small intestinal inflammation similar to celiac disease in teriflunomide associated diarrhea.

Keywords: Celiac disease; Diarrhea; Disease modifying therapies; Gastroenteritis; Multiple Sclerosis; Teriflunomide.

Publication types

  • Letter

MeSH terms

  • Crotonates* / adverse effects
  • Diarrhea / chemically induced
  • Humans
  • Hydroxybutyrates
  • Nitriles
  • Toluidines* / adverse effects

Substances

  • Crotonates
  • Hydroxybutyrates
  • Nitriles
  • Toluidines
  • teriflunomide